chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 21.0
Sex: M
Vaccine: FLUX, MEN, TD
Symptoms: Facial palsy, Guillain-Barre syndrome, Hypoaesthesia, Muscular weakness, Vision blurred
Clinical narrative: Symptoms Weakness in the arms, and legs. Numbness all over body, left facial droop, blurry vision. It took all of three weeks to take over entire body.  Diagnoses Guillain-Barre Syndrome  Treatment Immunoglobin Gamma Globulin
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Hyperhidrosis, Hypoaesthesia, Hypokinesia, Pain, Vomiting
Clinical narrative: Pt called with the following symptoms 2 days after receiving Menactra:  numbness in her fingers, body aches, sweating, emesis, and difficulty moving her legs from the hips down.  It lasted for a half hour and resolved with motrin.  The next day she felt "foggy" and her affect was a bit off.  Pt was back to baseline the following day.
Age: 15.0
Sex: F
Vaccine: MNQ
Symptoms: Dizziness, Dyspnoea, Headache, Hypoaesthesia, Pyrexia
Clinical narrative: PATIENT RECEIVED MENACTRA ON 10/10/2005. THAT EVENING SHE HAD FEVER, HEADACHE, DIZZINESS AND A SUBJECTIVE FEELING OF DIFFICULTY BREATHING. SHE ALSO FELT LIKE HER ENTIRE BODY FELT NUMB FOR ABOUT 5 MINUTES. HOWEVER WHEN SHE RETURNED THE NEXT DAY FOR CHECK MOST OF THESE SYMPTOMS HAD RESOLVED AND SHE HAD A NORMAL NEUROLOGIC EXAM.
Age: 81.0
Sex: F
Vaccine: FLU3
Symptoms: Nausea, Vomiting
Clinical narrative: Pt experienced Nausea and vomiting 1 - 1 1/2 hours after getting flu vaccine. Advised pt to see DR but pt went home, husband called and said she was better, probably car sick plus empty stomach.
Age: 1.48
Sex: F
Vaccine: DTAPH, FLU3
Symptoms: Oedema, Purpura, Urticaria, White blood cell count increased
Clinical narrative: In 2 hrs pt developed swelling and purpura to upper parts of both legs and urticaria all over body pt was given Benadryl.
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Decreased appetite, Headache, Nausea, Pain
Clinical narrative: Pt refers started with knee pains on 10/03/2005, then body aches, fever, headache, decreased appetite, nausea with vomiting x 2 on 10/04/2005. Was seen by MD on 10/05/2005 V/S fer 112 BPM, BP 12/68, T 100.0, recommended bedrest, Tylenol G 4hr and increased fluids.
Sex: F
Vaccine: FLU3
Symptoms: Pyrexia, Vomiting
Clinical narrative: Pt refers started with knee pains on 10/03/2005, then body aches, fever, headache, decreased appetite, nausea with vomiting x 2 on 10/04/2005. Was seen by MD on 10/05/2005 V/S fer 112 BPM, BP 12/68, T 100.0, recommended bedrest, Tylenol G 4hr and increased fluids.
Sex: F
Vaccine: FLUX
Symptoms: Dizziness, Dysphonia, Hyperhidrosis, Nausea, Pruritus
Clinical narrative: Itching started at night and got progressively worse to the point of hives. On 10/07 felt nauseated, dizzy, woke up with perspiration. 10/11 called doctor and waiting for prescriptions to arrive. Complains of hoarseness.
Sex: F
Vaccine: FLUX
Symptoms: Urticaria
Clinical narrative: Itching started at night and got progressively worse to the point of hives. On 10/07 felt nauseated, dizzy, woke up with perspiration. 10/11 called doctor and waiting for prescriptions to arrive. Complains of hoarseness.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site hypersensitivity, Injection site oedema, Pyrexia
Clinical narrative: On 03/07/2005 DTap, IVP given in LA within 2 day arm became increased swollen, red and had fever to 101. Taken to ER given 1 week of ice packs and Motrin.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Musculoskeletal stiffness
Clinical narrative: Neck stiffness approx 72 after vaccine administration, no signs or symptoms of Guillain Barre.
Age: 1.16
Sex: M
Vaccine: PNC, VARCEL
Symptoms: Viral infection
Clinical narrative: Developed chicken pox rash.
Age: 1.03
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Viral infection
Clinical narrative: Pt with chicken pox 10/08/2005
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Chest discomfort, Chest pain, Fatigue, Heart rate increased, Hyperhidrosis
Clinical narrative: Pt experienced chest pains after running (1 mile run)/ Pt is very athletic ans has never had such problems Pt better after 40 minutes. Problems have continued for 5-6 weeks. Also complains of shortness of breath, fatigue, fast heart beat. Had a doctor visit on 08/12, and there was no wheezing, possibly bronchial spasms diagnosed as exercise induced asthma. Has been taking Claritin for 5 weeks and uses inhaler. Pt had 2 EKG's and elect no cardiogram to rule out heart problem. Today pt not at full capacity in practice in opposed to during games because of more break time.
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Asthma, Chest pain, Dyspnoea, Fatigue, Heart rate increased
Clinical narrative: Pt experienced chest pains after running (1 mile run)/ Pt is very athletic ans has never had such problems Pt better after 40 minutes. Problems have continued for 5-6 weeks. Also complains of shortness of breath, fatigue, fast heart beat. Had a doctor visit on 08/12, and there was no wheezing, possibly bronchial spasms diagnosed as exercise induced asthma. Has been taking Claritin for 5 weeks and uses inhaler. Pt had 2 EKG's and elect no cardiogram to rule out heart problem. Today pt not at full capacity in practice in opposed to during games because of more break time.
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Muscle spasms
Clinical narrative: Pt experienced chest pains after running (1 mile run)/ Pt is very athletic ans has never had such problems Pt better after 40 minutes. Problems have continued for 5-6 weeks. Also complains of shortness of breath, fatigue, fast heart beat. Had a doctor visit on 08/12, and there was no wheezing, possibly bronchial spasms diagnosed as exercise induced asthma. Has been taking Claritin for 5 weeks and uses inhaler. Pt had 2 EKG's and elect no cardiogram to rule out heart problem. Today pt not at full capacity in practice in opposed to during games because of more break time.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Similar reaction on previous exposure to drug, Syncope, Visual disturbance, Visual field defect
Clinical narrative: Initial report was received on Oct 06 2005 from a health care professional and follow up information on Oct 07 2005 from the responsible physician. An 18 year old female was vaccinated with Menactra, lot number U1525AB, in the left deltoid on Jul 08 2005. the patient has a history of fainting after all prior vaccines and had an unspecified reaction after receiving an MMR immunization 10 to 12 years previously, On Jul 08 2005, approximately 15 minutes post vaccination, the patient felt like fainting. She became shaky, scared and panicky. Her blood pressure was low ans she was tachycardic. Her blood pressure was 120/80 and her pulse 94 and regular, but her blood pressure decreased to 100/60 and her heart rate increased to 110 when she attempted to sit up. her mother reported that the patient also developed tingling in her hands and feet. The patient was taken to an ER and was treated with intravenous fluids and her blood pressure improved. She was told her symptoms were due to anxiety and she was sent home with prednisone, Benadryl and Xanax. the overall impression was that the patient experienced a vasovagal response and severe anxiety attack. The patient reportedly felt fine for several weeks post vaccination and then began to notice a change in her vision. Four weeks post vaccination the patient developed tunnel vision in both eyes. The lower visual field in her right eye had bright/dark spots in it. When she went to see an ophthalmologist she became panicky and refused a dilated examination. She was seen by her primary physician on Aug 29 2005, at which time her visual fields by confrontation appeared to confirm her description of poor vision in the right inferior visual field of both eyes. She was referred back to the ophthalmologist for more complete visual field testing, which was also abnormal. An MRI of the brain with contrast was normal. She was referred to a neuro ophthalmologist who reportedly said he was not sure what was going on, but was not worried by her symptoms. As of Oct 06 2005, the patient's mother reported that the patients symptoms had not improved. As per the responsible physician, the patients outcome at the time of this report is unknown. The initial report noted that this was a possible case of Guillain Barre syndrome, but no mention of this was noted in the physicians notes.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Anxiety, Blood pressure decreased, Dizziness, Heart rate increased, Panic reaction
Clinical narrative: Initial report was received on Oct 06 2005 from a health care professional and follow up information on Oct 07 2005 from the responsible physician. An 18 year old female was vaccinated with Menactra, lot number U1525AB, in the left deltoid on Jul 08 2005. the patient has a history of fainting after all prior vaccines and had an unspecified reaction after receiving an MMR immunization 10 to 12 years previously, On Jul 08 2005, approximately 15 minutes post vaccination, the patient felt like fainting. She became shaky, scared and panicky. Her blood pressure was low ans she was tachycardic. Her blood pressure was 120/80 and her pulse 94 and regular, but her blood pressure decreased to 100/60 and her heart rate increased to 110 when she attempted to sit up. her mother reported that the patient also developed tingling in her hands and feet. The patient was taken to an ER and was treated with intravenous fluids and her blood pressure improved. She was told her symptoms were due to anxiety and she was sent home with prednisone, Benadryl and Xanax. the overall impression was that the patient experienced a vasovagal response and severe anxiety attack. The patient reportedly felt fine for several weeks post vaccination and then began to notice a change in her vision. Four weeks post vaccination the patient developed tunnel vision in both eyes. The lower visual field in her right eye had bright/dark spots in it. When she went to see an ophthalmologist she became panicky and refused a dilated examination. She was seen by her primary physician on Aug 29 2005, at which time her visual fields by confrontation appeared to confirm her description of poor vision in the right inferior visual field of both eyes. She was referred back to the ophthalmologist for more complete visual field testing, which was also abnormal. An MRI of the brain with contrast was normal. She was referred to a neuro ophthalmologist who reportedly said he was not sure what was going on, but was not worried by her symptoms. As of Oct 06 2005, the patient's mother reported that the patients symptoms had not improved. As per the responsible physician, the patients outcome at the time of this report is unknown. The initial report noted that this was a possible case of Guillain Barre syndrome, but no mention of this was noted in the physicians notes.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Paraesthesia, Syncope vasovagal, Tremor, Tunnel vision, Visual acuity reduced
Clinical narrative: Initial report was received on Oct 06 2005 from a health care professional and follow up information on Oct 07 2005 from the responsible physician. An 18 year old female was vaccinated with Menactra, lot number U1525AB, in the left deltoid on Jul 08 2005. the patient has a history of fainting after all prior vaccines and had an unspecified reaction after receiving an MMR immunization 10 to 12 years previously, On Jul 08 2005, approximately 15 minutes post vaccination, the patient felt like fainting. She became shaky, scared and panicky. Her blood pressure was low ans she was tachycardic. Her blood pressure was 120/80 and her pulse 94 and regular, but her blood pressure decreased to 100/60 and her heart rate increased to 110 when she attempted to sit up. her mother reported that the patient also developed tingling in her hands and feet. The patient was taken to an ER and was treated with intravenous fluids and her blood pressure improved. She was told her symptoms were due to anxiety and she was sent home with prednisone, Benadryl and Xanax. the overall impression was that the patient experienced a vasovagal response and severe anxiety attack. The patient reportedly felt fine for several weeks post vaccination and then began to notice a change in her vision. Four weeks post vaccination the patient developed tunnel vision in both eyes. The lower visual field in her right eye had bright/dark spots in it. When she went to see an ophthalmologist she became panicky and refused a dilated examination. She was seen by her primary physician on Aug 29 2005, at which time her visual fields by confrontation appeared to confirm her description of poor vision in the right inferior visual field of both eyes. She was referred back to the ophthalmologist for more complete visual field testing, which was also abnormal. An MRI of the brain with contrast was normal. She was referred to a neuro ophthalmologist who reportedly said he was not sure what was going on, but was not worried by her symptoms. As of Oct 06 2005, the patient's mother reported that the patients symptoms had not improved. As per the responsible physician, the patients outcome at the time of this report is unknown. The initial report noted that this was a possible case of Guillain Barre syndrome, but no mention of this was noted in the physicians notes.
Age: 18.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Visual disturbance
Clinical narrative: Initial report was received on Oct 06 2005 from a health care professional and follow up information on Oct 07 2005 from the responsible physician. An 18 year old female was vaccinated with Menactra, lot number U1525AB, in the left deltoid on Jul 08 2005. the patient has a history of fainting after all prior vaccines and had an unspecified reaction after receiving an MMR immunization 10 to 12 years previously, On Jul 08 2005, approximately 15 minutes post vaccination, the patient felt like fainting. She became shaky, scared and panicky. Her blood pressure was low ans she was tachycardic. Her blood pressure was 120/80 and her pulse 94 and regular, but her blood pressure decreased to 100/60 and her heart rate increased to 110 when she attempted to sit up. her mother reported that the patient also developed tingling in her hands and feet. The patient was taken to an ER and was treated with intravenous fluids and her blood pressure improved. She was told her symptoms were due to anxiety and she was sent home with prednisone, Benadryl and Xanax. the overall impression was that the patient experienced a vasovagal response and severe anxiety attack. The patient reportedly felt fine for several weeks post vaccination and then began to notice a change in her vision. Four weeks post vaccination the patient developed tunnel vision in both eyes. The lower visual field in her right eye had bright/dark spots in it. When she went to see an ophthalmologist she became panicky and refused a dilated examination. She was seen by her primary physician on Aug 29 2005, at which time her visual fields by confrontation appeared to confirm her description of poor vision in the right inferior visual field of both eyes. She was referred back to the ophthalmologist for more complete visual field testing, which was also abnormal. An MRI of the brain with contrast was normal. She was referred to a neuro ophthalmologist who reportedly said he was not sure what was going on, but was not worried by her symptoms. As of Oct 06 2005, the patient's mother reported that the patients symptoms had not improved. As per the responsible physician, the patients outcome at the time of this report is unknown. The initial report noted that this was a possible case of Guillain Barre syndrome, but no mention of this was noted in the physicians notes.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR, DTAP, IPV, MMR
Symptoms: Erythema, Injection site induration
Clinical narrative: Right thigh with approximately 10.5 cm2 area of erythema and induration.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Abnormal behaviour, Gait disturbance, Headache, Pyrexia, Restlessness
Clinical narrative: Per pts guardian, began 10/10/2005 to have increased fever, complain of headache, vomiting. Seen in clinic 10/11/2005 with altered behavior, stumbling, restless, tremor, pacing, non verbal, VS; BP 112/68, T 99, P 118, R 24, To ER via ambulance for evaluation.
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Tremor, Vomiting
Clinical narrative: Per pts guardian, began 10/10/2005 to have increased fever, complain of headache, vomiting. Seen in clinic 10/11/2005 with altered behavior, stumbling, restless, tremor, pacing, non verbal, VS; BP 112/68, T 99, P 118, R 24, To ER via ambulance for evaluation.
Age: 61.0
Sex: F
Vaccine: HEPA, YF
Symptoms: Face oedema, Pruritus, Urticaria
Clinical narrative: Hives on face, itchy, facial swelling, did not start until 10/02/2005.
Sex: U
Vaccine: MMR
Symptoms: Autism
Clinical narrative: Information has been received from a RN concerning a pt who was vaccinated SC with a 0.5mL dose of measles virus vaccine live  (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 641088/1347L). Subsequently the pt experienced autism. Unspecified medical attention was sought. The outcome was reported as not recovered. There was no product quality complaint. No further information is available. Follow up information received from a RN indicated that she had absolutely no additional information, and did not expect to obtain any additional information. Upon internal review, autism was considered to be an other important medical event (OMIC). No additional information is expected.
Age: 67.0
Sex: F
Vaccine: PPV
Symptoms: Injection site oedema, Pruritus
Clinical narrative: Information has been received from a physician and a healthcare worker concerning a 67 yr old female with a penicillin allergy who on 27Sep05 was vaccinated SC in the left arm with a 0.5mL second dose of pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). In the evening on 27Sep05, the pt's left arm was itchy and swollen. By the next morning, The swelling worsened. On 28Sep05, the pt presented to the physicians office and was treated with fexofenadine hydrochloride (Allegra), a methyl prednisolone (Medrol) dose pack, and levofloxacin (Levaquin). A follow up visit was scheduled on 30Sep05. No diagnostic lab tests were performed. The physician requested a lot check. Results are pending. Left arm itching and swelling were considered to be other important medical events (OMIC) by the reporter. Additional information has been requested.
Age: 50.0
Sex: F
Vaccine: PPV
Symptoms: Erythema, Injection site erythema, Skin warm
Clinical narrative: Information has been received from a physician and a healthcare worker concerning a 50 year old female with sulfa and amoxicillin (+) clavulanate potassium allergies who on 9/27/05 was vaccinated SC in the left arm with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot # 650453/0791P). On 9/29/05, the patient presented to the physician's office with a right upper extremity that was red, warm, and patchy. The healthcare worker noted a discrepancy in the documentation because the client was vaccinated in the left arm, but the adverse event was documented in the right arm. The patient was treated with a methylprednisolone dose pack. No diagnostic laboratory tests were performed. The physician requested a lot check. Results are pending. Right upper extremity that was red, warm and patchy was considered to be an other important medical event by the reporter (OMIC). Additional information has been requested.
Age: 44.0
Sex: M
Vaccine: PPV
Symptoms: Injection site oedema
Clinical narrative: Information has been received from a physician and a healthcare worker concerning a 44 year old male with who on 17Aug05 was vaccinated SC in the left arm with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot650453/0791P).  It was noted that the lot number was also reported as unk, although the physician believed it was lot 650453/0791P.  The pt presented to the physician's office on 18Aug05 with a swollen left arm pt was treated with a methylprednisolone (Medrol) dose pack and diphenhydramine hydrochloride (Benadryl). No diagnostic lab tests were performed. The physician requested a lot check. Results are pending. Swollen left arm was considered to be an other important medical event (OMIC) by the reporter. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: HEPA
Symptoms: Abasia, Coma, Diplopia, Dysarthria, Hypoxia
Clinical narrative: Information has been received from a physician concerning a healthy 5.5 year old female with a history of strep throat and no allergies who in early 2005 (approximately January 2005), was vaccinated with a first dose of hepatitis A virus vaccine inactivated and on 9/15/05 was vaccinated with a second dose of hepatitis A virus vaccine inactivated (lot # 649459/0287R). There was no concomitant medication. On 9/25/05, 10 days after vaccination, the patient developed double vision. On 9/26/05, the patient was unable to get out of bed and unable to walk. Two to three hours later, her speech became slurred and she had mental status changes. She was taken to the emergency room and was unable to walk or talk. She was admitted to the hospital and within 30 minutes was intubated. She was given IV immune globulin. She became unresponsive and her status was worsening. Plasmaphoresis was initiated. A methylprednisolone sodium succinate pulse was begun in the morning of 9/30/05. .She was also given Cytoxin. An MRI and MRA were performed (results not provided). Laboratory tests included CSF (test not specified) and a sedimentation rate and C-reactive protein were high. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Double vision, unable to get out of bed/unable to walk, speech became slurred, mental status changes, unable to talk, and unresponsive were considered to be immediately life threatening, disabling, and other important medical events by the physician (OMIC). Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: HEPA
Symptoms: Laboratory test abnormal, Mental impairment, Red blood cell abnormality, Speech disorder
Clinical narrative: Information has been received from a physician concerning a healthy 5.5 year old female with a history of strep throat and no allergies who in early 2005 (approximately January 2005), was vaccinated with a first dose of hepatitis A virus vaccine inactivated and on 9/15/05 was vaccinated with a second dose of hepatitis A virus vaccine inactivated (lot # 649459/0287R). There was no concomitant medication. On 9/25/05, 10 days after vaccination, the patient developed double vision. On 9/26/05, the patient was unable to get out of bed and unable to walk. Two to three hours later, her speech became slurred and she had mental status changes. She was taken to the emergency room and was unable to walk or talk. She was admitted to the hospital and within 30 minutes was intubated. She was given IV immune globulin. She became unresponsive and her status was worsening. Plasmaphoresis was initiated. A methylprednisolone sodium succinate pulse was begun in the morning of 9/30/05. .She was also given Cytoxin. An MRI and MRA were performed (results not provided). Laboratory tests included CSF (test not specified) and a sedimentation rate and C-reactive protein were high. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Double vision, unable to get out of bed/unable to walk, speech became slurred, mental status changes, unable to talk, and unresponsive were considered to be immediately life threatening, disabling, and other important medical events by the physician (OMIC). Additional information has been requested.
Age: 21.0
Sex: F
Vaccine: HEP, MEN
Symptoms: Abasia, Asthenia, Guillain-Barre syndrome, Hypokinesia
Clinical narrative: Initial report received on Oct 03 2005 about a consumer report. A 21 year old female stated that she received Meningitis vaccine and Hepatitis B vaccine #1 on Oct 10 2003, Hepatitis B vaccine #2 on Jan 22 2004 and Hepatitis B vaccine #3 on Dec 0 2004, no lot numbers were provided. She was vaccinated at her college student health center. Then, in April 2005, she had arm and leg weakness and was hospitalized from April 21 2005 in her college town and transferred to another hospital in Atlanta from May 14 2005 to May 19 2005. She was then in a rehab hospital from may 19 2005 to June 14 2005. She said she had a GBS like illness. She is now wheelchair bound and is unable to lift her arms. Her immunization record have been requested and a VAERS report will be submitted.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Asthenia, Erythema, Platelet count increased, Thrombocytopenia, Tongue black hairy
Clinical narrative: Initial report received from the patient's parent on 10/4/05. A 17 year old male with no previous medical history received an injection of Menactra, lot number unknown, on 6/29/05. The route and site of administration were also unknown. Seven days later, the patient developed red spots on his skin throughout his body, black stops on his tongue and felt weak. He was examined in a clinic and referred to a hematologist for evaluation. The hematologist diagnosed thrombocytopenia, and the patient was hospitalized for six days at which time he was treated per the reporter with gammaglobulin and high doses of prednisone. The platelets increased. Approximately two weeks prior to this report, the patient was feeling weak again. A repeat CBC and platelet count were within normal limits. At the time of this report, the client had recovered but continued to be monitored.
Age: 19.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Headache, Malaise, Meningitis, Muscular weakness
Clinical narrative: Initial report received from a parent in the USA on 10/03/05. A female patient (age not reported) reportedly developed bacterial meningitis 13 days after she received an injection of Menactra vaccine on 8/3/05 (lot number, route and site of administration not reported). The patient is home from the hospital. The parent stated that their daughter is still pretty sick and it had been 6 weeks since she was diagnosed with BM. The parent felt that her daughter should be making progress with her recovery, but she does not feel she is doing so. Follow up information received on 10/6/05. The patient is an 18 year old female who developed malaise, 3 hours after she received an injection of Menactra, lot number U1741AB (route and site of administration not reported) on 8/3/05. On 8/16/05, she developed headache and leg weakness. She went to the hospital where a spinal tap was taken and found to be positive for meningitis (no strain identified). She was treated with antibiotics and discharged on 8/26/05. On 8/28/05, she developed post-meningitis headache and continuing leg weakness. She was readmitted to hospital where she was given a spinal patch with DHE and steroids. She was discharged on 8/30/05. On 9/3/05, she was readmitted to another hospital for continued weakness and discharged on 9/7/05. She went to the same hospital on 10/6/05 complaining of continued leg weakness. The patient also had a CT head - within normal limits and MRI with contrast, but no dates were provided. As per the parent, the patient has not recovered.
Age: 19.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Headache, Hyperacusis, Meningitis, Migraine, Musculoskeletal stiffness
Clinical narrative: Initial report received from a parent in the USA on 10/03/05. A female patient (age not reported) reportedly developed bacterial meningitis 13 days after she received an injection of Menactra vaccine on 8/3/05 (lot number, route and site of administration not reported). The patient is home from the hospital. The parent stated that their daughter is still pretty sick and it had been 6 weeks since she was diagnosed with BM. The parent felt that her daughter should be making progress with her recovery, but she does not feel she is doing so. Follow up information received on 10/6/05. The patient is an 18 year old female who developed malaise, 3 hours after she received an injection of Menactra, lot number U1741AB (route and site of administration not reported) on 8/3/05. On 8/16/05, she developed headache and leg weakness. She went to the hospital where a spinal tap was taken and found to be positive for meningitis (no strain identified). She was treated with antibiotics and discharged on 8/26/05. On 8/28/05, she developed post-meningitis headache and continuing leg weakness. She was readmitted to hospital where she was given a spinal patch with DHE and steroids. She was discharged on 8/30/05. On 9/3/05, she was readmitted to another hospital for continued weakness and discharged on 9/7/05. She went to the same hospital on 10/6/05 complaining of continued leg weakness. The patient also had a CT head - within normal limits and MRI with contrast, but no dates were provided. As per the parent, the patient has not recovered.
Age: 19.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Pain, Photophobia, Viral infection
Clinical narrative: Initial report received from a parent in the USA on 10/03/05. A female patient (age not reported) reportedly developed bacterial meningitis 13 days after she received an injection of Menactra vaccine on 8/3/05 (lot number, route and site of administration not reported). The patient is home from the hospital. The parent stated that their daughter is still pretty sick and it had been 6 weeks since she was diagnosed with BM. The parent felt that her daughter should be making progress with her recovery, but she does not feel she is doing so. Follow up information received on 10/6/05. The patient is an 18 year old female who developed malaise, 3 hours after she received an injection of Menactra, lot number U1741AB (route and site of administration not reported) on 8/3/05. On 8/16/05, she developed headache and leg weakness. She went to the hospital where a spinal tap was taken and found to be positive for meningitis (no strain identified). She was treated with antibiotics and discharged on 8/26/05. On 8/28/05, she developed post-meningitis headache and continuing leg weakness. She was readmitted to hospital where she was given a spinal patch with DHE and steroids. She was discharged on 8/30/05. On 9/3/05, she was readmitted to another hospital for continued weakness and discharged on 9/7/05. She went to the same hospital on 10/6/05 complaining of continued leg weakness. The patient also had a CT head - within normal limits and MRI with contrast, but no dates were provided. As per the parent, the patient has not recovered.
Age: 0.5
Sex: F
Vaccine: DTAP, HIBV, IPV, PNC
Symptoms: Erythema, Inflammation, Pyrexia, Rhinorrhoea, Swelling
Clinical narrative: Patient developed fever, runny nose for 1 week. Was seen and put on Augmentin 200 5/cc 3/4tsp BID for 10 days. Patient then returned with left ear red, swollen. Patient was then referred to ENT. Diagnosed with mastoiditis.
Age: 1.28
Sex: F
Vaccine: FLU3, HIBV, MMR, PNC
Symptoms: Apnoea, Confusional state, Convulsion, Electroencephalogram abnormal, Eye disorder
Clinical narrative: Status epilepticus for 30 minutes. Ativan, Phenytine, intubated, 39C temperature. Continued seizures trilepta. Information from discharge summary states eye disorder, rash, somnolance, confusion, paralysis, apnea. msv Medical records states fever. msv
Age: 1.28
Sex: F
Vaccine: FLU3, HIBV, MMR, PNC
Symptoms: Hypoxia, Paralysis, Pyrexia, Rash, Somnolence
Clinical narrative: Status epilepticus for 30 minutes. Ativan, Phenytine, intubated, 39C temperature. Continued seizures trilepta. Information from discharge summary states eye disorder, rash, somnolance, confusion, paralysis, apnea. msv Medical records states fever. msv
Age: 1.28
Sex: F
Vaccine: FLU3, HIBV, MMR, PNC
Symptoms: Status epilepticus
Clinical narrative: Status epilepticus for 30 minutes. Ativan, Phenytine, intubated, 39C temperature. Continued seizures trilepta. Information from discharge summary states eye disorder, rash, somnolance, confusion, paralysis, apnea. msv Medical records states fever. msv
Age: 1.7
Sex: F
Vaccine: DTAP, FLU3
Symptoms: Croup infectious, Laboratory test abnormal, Respiratory syncytial virus infection
Clinical narrative: Pt had no adverse reactions with imms. Pt admitted to hosp on 9/30/05 for croup x 24 hrs.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: Cardiac disorder, Palpitations
Clinical narrative: Pt experienced cardiac palpitations the day after Menactra was given. Normal EKG at the time was evaluated. Currently having follow up with cardiac event monitor.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Discomfort, Feeling hot, Injection site erythema, Injection site hypersensitivity, Injection site oedema
Clinical narrative: Approx 24 hours after Menactra vaccine was given sub Q. left arm, injection site developed redness, swelling and discomfort. 48 Hours post injection site was 50mm erythematous, warm to touch, swollen and arm was painful when moved. Treated with hydrocortisone cream 1% TID and Motrin 600mg TID.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Pain
Clinical narrative: Approx 24 hours after Menactra vaccine was given sub Q. left arm, injection site developed redness, swelling and discomfort. 48 Hours post injection site was 50mm erythematous, warm to touch, swollen and arm was painful when moved. Treated with hydrocortisone cream 1% TID and Motrin 600mg TID.
Age: 18.0
Sex: M
Vaccine: MNQ
Symptoms: Hyperhidrosis, Injection site reaction, Muscular weakness, Pain
Clinical narrative: Vaccine given at 8am on 09/27/2005. On 09/28/2005 at approximately 1am developed soreness at injection site profuse diaphoresis and muscle weakness in both legs. Continued throughout day until 09/29/2005 am when he felt no further symptoms.
Age: 13.0
Sex: F
Vaccine: TDAP
Symptoms: Arthralgia, Chills, Myalgia, Pyrexia, Vomiting
Clinical narrative: Fever 103.5, chills, joint and muscle aches, vomiting. No treatment except fluids
Age: 0.56
Sex: M
Vaccine: DTAP, FLU3, PNC
Symptoms: Incorrect dose administered
Clinical narrative: NONE Per annual report-.5ml given instead of 0.25ml
Age: 12.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site hypersensitivity, Injection site oedema
Clinical narrative: Localized swelling and redness of injection site.
Age: 5.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMR
Symptoms: Erythema, Oedema
Clinical narrative: Swelling, Erythema right deltoid 7.5 x 10.5 cm.
Age: 0.51
Sex: M
Vaccine: DTAP, FLU3, HIBV, PNC
Symptoms: Urticaria
Clinical narrative: Diffuse Urticaria noted by mom approx. 1 1/2 hrs after vaccine administration. PE in office, Urticaria trunk, extremities and sl or face. No respiratory changes. No wheezing, stridor.
Age: 68.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Tenderness
Clinical narrative: Red, tender at injection site. No signs of infection.
Age: 0.74
Sex: F
Vaccine: FLU3
Symptoms: Dyspnoea, Eyelid oedema, Hypersensitivity, Urticaria, Wheezing
Clinical narrative: Eyelid swelling, wheezing, hives 10/17/05 Review of medical records indicates chief complaint of "swelling around eyes ? allergic reaction to flu vaccine". Final diagnosis was stated as "Acute Allergic Reaction" (not otherwise specified). Additional symptom noted was "trouble breathing".
Age: 35.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Injection site oedema, Injection site pain
Clinical narrative: Pt c/o soreness and swelling in left arm from elbow to shoulder 4 hrs after vaccination. She went to Dr the next day and received treatment.
Age: 24.0
Sex: F
Vaccine: TDAP
Symptoms: Convulsion, Pyrexia, Syncope, Vomiting
Clinical narrative: 9/23/05 vaccine given, temp peaking at 101 with assoc vomiting until 9/26/05 symptoms resolved. 10/4/05 fainting spell at work. Seen ER at hosp. Seizure episode in differential although no clonic-tonic movements seen EEG. Neuro consult pending. Pt had full series of DTP as an infant w/o reaction.
Age: 77.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Heart rate increased, Hyperhidrosis
Clinical narrative: Rapid heartbeat (92-regular 54), sweating, dizzy, took 6 Nitroglycerin sl tabs to treat.
Age: 15.0
Sex: F
Vaccine: MNQ, TD
Symptoms: Hypoaesthesia
Clinical narrative: This is 14 y/o female who received Menactra on 9/16/05 and two wk later had numbness of arm for 1 wk and now has resolved. The twin sister also had shot but no complaints.
Age: 29.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Medication error, Unintended pregnancy
Clinical narrative: Varicella and MMR given within 30 days of pt finding out she was pregnant.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Dyspnoea, Injection site erythema, Injection site hypersensitivity, Pruritus
Clinical narrative: I received the injection on 10/7/05.  Approximately 3-5 minutes after receiving the vaccine I had a local reaction as e/b itching & redness at the site.  Approximately 10 minutes after receiving the vaccine I became short of breath & started to wheeze & cough.  I then went to the ER & received treatment. I had solumedrol IV, Benadryl 50 mg IV, Prednisone 30mg orally and  neb treatment. I was also started on a Solumedrol pack which I started on 10/8/05.
Age: 44.0
Sex: F
Vaccine: FLU3
Symptoms: Wheezing
Clinical narrative: I received the injection on 10/7/05.  Approximately 3-5 minutes after receiving the vaccine I had a local reaction as e/b itching & redness at the site.  Approximately 10 minutes after receiving the vaccine I became short of breath & started to wheeze & cough.  I then went to the ER & received treatment. I had solumedrol IV, Benadryl 50 mg IV, Prednisone 30mg orally and  neb treatment. I was also started on a Solumedrol pack which I started on 10/8/05.
Age: 26.0
Sex: F
Vaccine: FLUN3
Symptoms: Cough, Eye swelling, Headache, Lacrimation increased, Nasal congestion
Clinical narrative: Approx. two days after taking FluMist, I got sore throat, runny and stuffed nose, swollen and runny eyes, non productive cough, general aches and pains and headache.
Age: 26.0
Sex: F
Vaccine: FLUN3
Symptoms: Pain, Pharyngolaryngeal pain, Rhinorrhoea
Clinical narrative: Approx. two days after taking FluMist, I got sore throat, runny and stuffed nose, swollen and runny eyes, non productive cough, general aches and pains and headache.
Age: 46.0
Sex: M
Vaccine: FLUN3
Symptoms: Arthralgia, Diarrhoea, Headache, Lacrimation increased, Myalgia
Clinical narrative: Headache, watery eyes, blurry vision, post-nasal drip, runny nose, sore throat, muscle and joint aches, low-grade fever (100),diarrhea. All symptoms occurred within 4 hrs of "Flu-Mist". treated with Motrin 800 mg /6 hrs and Dayquil.
Age: 46.0
Sex: M
Vaccine: FLUN3
Symptoms: Pharyngolaryngeal pain, Postnasal drip, Pyrexia, Rhinorrhoea, Vision blurred
Clinical narrative: Headache, watery eyes, blurry vision, post-nasal drip, runny nose, sore throat, muscle and joint aches, low-grade fever (100),diarrhea. All symptoms occurred within 4 hrs of "Flu-Mist". treated with Motrin 800 mg /6 hrs and Dayquil.
Age: 46.0
Sex: M
Vaccine: YF
Symptoms: Rash, Rash macular, Rash pruritic
Clinical narrative: Red "blotchy" rash which started on the left arm 10/7/05 and spread over the entire body in the next two days. States the rash is itching. Denies fever. Has seen his physician and is taking Benadryl.
Age: 17.0
Sex: M
Vaccine: HEPA, MNQ
Symptoms: Chills, Pyrexia, Tremor
Clinical narrative: Was seen in the office 10/11/05 at approximately 1500 for a well child exam.  He was in good health at the time of the exam without any symptoms of illness.  He was given Hepatitis A vaccine and Menactra.  Approximately 12 hours later he presented to the Emergency Department with fever (103.1), chills and shaking.  His CBC was slightly elevated in the ER to 11.4.  His ALT was 129, however this was a known medical problem.  He was discharged to home, and followed up in the PCP office in the am with mild URI symptoms and afebrile.
Age: 52.0
Sex: F
Vaccine: FLU3
Symptoms: Pruritus, Urticaria
Clinical narrative: Patient began with itching and "hives" 24 hours after getting vaccine.  Also reports new blanket on bed.  Taking over the counter Benadryl and Alavert.  States not severe enough to be seen by PCP.
Age: 84.0
Sex: M
Vaccine: FLU3
Symptoms: Dizziness, Nausea, Vomiting
Clinical narrative: Night after I got shot. Woke up around 2 am. Threw up and sick to my stomach. Was dizzy which lasted for about six weeks. Don't know if I had a adverse effect. But now afraid to get flu shot this year.
Age: 4.0
Sex: M
Vaccine: DTAP, FLU3, IPV, MMR
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Myalgia, Fever up to 101, Chills.  Treat with Tylenol or Motrin, Bath/Ice Packs, Pushe fluids.
Age: 11.0
Sex: M
Vaccine: FLU3
Symptoms: Asthma, Convulsion
Clinical narrative: Flu vaccine administered at 11AM, 8 hrs later had seizure asthma episode 911 was called, dx'd at ER, sent home same day.
Age: 13.0
Sex: M
Vaccine: TDAP
Symptoms: Injection site erythema, Urticaria
Clinical narrative: Entire body turned bright red with hives from head to toe per moms report.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Feeling hot, Injection site erythema, Injection site oedema, Viral infection
Clinical narrative: Right thigh with 5-6 inches of redness/swelling, warm to touch. Dr to evaluate. Benadryl q 6 hr, Motrin. S/s of infection. Mom denies fever.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Injection site erythema, Injection site mass, Injection site pain
Clinical narrative: Pain, erythema and induration to RUE from shoulder to elbow area.
Age: 57.0
Sex: F
Vaccine: PPV, TD
Symptoms: Erythema, Injection site oedema, Injection site pain
Clinical narrative: Swelling and Pain and redness right arm
Age: 39.0
Sex: F
Vaccine: HEPAB
Symptoms: Dysphonia, Nausea, Pain
Clinical narrative: Vaccine received 10/10/05 approx 8:30-9:00AM. Pt felt soreness left side. Became nauseated during night, no vomiting. This am woke up with sore left arm, side, left neck area and with hoarseness.
Age: 76.0
Sex: F
Vaccine: PPV
Symptoms: Feeling hot, Hypersensitivity, Lymphadenopathy, Nausea, Pain
Clinical narrative: Client returned to clinic morning after vaccine was done the day before. Hive-type rash, urticaria noted on left upper arm and on face, forehead area. Left upper arm warm to touch. Also c/o nausea. No s/s of respiratory distress, states s/s began the evening same day of vaccine. Referred to PMD. Dx: allergic reaction and ordered warm compresses and Clarinex. Also noted swollen lymph node. Left Ax area. Hx of PCN allergy. Also c/o pain left arm.
Age: 76.0
Sex: F
Vaccine: PPV
Symptoms: Rash, Urticaria
Clinical narrative: Client returned to clinic morning after vaccine was done the day before. Hive-type rash, urticaria noted on left upper arm and on face, forehead area. Left upper arm warm to touch. Also c/o nausea. No s/s of respiratory distress, states s/s began the evening same day of vaccine. Referred to PMD. Dx: allergic reaction and ordered warm compresses and Clarinex. Also noted swollen lymph node. Left Ax area. Hx of PCN allergy. Also c/o pain left arm.
Age: 83.0
Sex: F
Vaccine: PPV
Symptoms: Feeling hot, Injection site erythema, Injection site pain
Clinical narrative: Received Pneumovax 10/7/2005 at 10PM same night woke up with severe pain in injection arm (rt) arm was red/warm went to ER for tx.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Feeling hot, Injection site erythema, Injection site oedema
Clinical narrative: Red, hot and swollen.
Age: 4.0
Sex: F
Vaccine: HIBV, PNC
Symptoms: Feeling hot, Injection site erythema, Injection site oedema, Pyrexia
Clinical narrative: Pt ran a fever red, hot, swollen about 3cm at injection site, no treatment given, just watch.
Age: 48.0
Sex: F
Vaccine: TD
Symptoms: Chest pain, Oedema, Pyrexia
Clinical narrative: Pt had routine Td 8/23/05. Reported to clinic next day with T 101.5 c/o chest pain, swelling, said it was from vaccine, sent to ER.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Injection site erythema, Injection site oedema, Injection site pain, Injection site reaction, Pruritus
Clinical narrative: Redness/swelling/itch/pain started 9/20/05 anterior left thigh, continued 9/21/05.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Vaccine positive rechallenge
Clinical narrative: Redness/swelling/itch/pain started 9/20/05 anterior left thigh, continued 9/21/05.
Age: 63.0
Sex: F
Vaccine: MMR
Symptoms: Injection site erythema, Injection site mass, Injection site oedema
Clinical narrative: Red swollen size of a half dollar, induration 1/2 cm.
Age: 7.0
Sex: F
Vaccine: DTAP
Symptoms: Medication error, Wrong drug administered
Clinical narrative: Dtap given instead of Td.
Age: 6.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Hypersensitivity, Oedema
Clinical narrative: Swelling and redness in left upper arm portion, round about 10 cm in diameter, non painful. Started yesterday afternoon, RX'd today with Benadryl/PRN.
Age: 4.0
Sex: M
Vaccine: DTAP, IPV, MMR
Symptoms: Hypersensitivity, Oedema
Clinical narrative: Right arm red, swollen.
Age: 0.17
Sex: F
Vaccine: DTAP, HEP, HIBV, IPV, PNC
Symptoms: Asthenia, Dyspnoea
Clinical narrative: After first set of immunizations, infant slept 4 hours. Upon awakening, infant appeared weak, gasping, unable to move air in. NO choking, not struggling. No cyanosis or duskiness. Lasted 20 min self resolved.
Age: 53.0
Sex: F
Vaccine: PPV
Symptoms: Injection site hypersensitivity, Injection site induration, Injection site oedema, Pyrexia
Clinical narrative: Induration at site of injection, redness, swelling, fever 101-102.
Sex: F
Vaccine: DTAPHEPBIP, VARCEL
Symptoms: Acne, Decreased appetite, Hypersensitivity, Pyrexia, Rash maculo-papular
Clinical narrative: Fever Started 09/23/2005. Temperature up to 103.8. Decreased appetite. Had red spots that looked like pimples, some of them with pus and raised with white color. Never crusted over. Seen at Clinic white on vacation probably reaction to vaccine. Mom states resolved by 09/27/2005.
Age: 56.0
Sex: F
Vaccine: PPV, TD, DT, PPV
Symptoms: Injection site hypersensitivity, Injection site oedema, Sensation of heaviness
Clinical narrative: Redness upper arm with swelling, brachial area of injection 12 x 25 mm area and 40 x 70 mm area plus arm is heavy. .
Age: 56.0
Sex: F
Vaccine: PPV, TD, DT, PPV
Symptoms: Abscess, Asthenia, Chest pain, Full blood count, Musculoskeletal stiffness
Clinical narrative: Redness upper arm with swelling, brachial area of injection 12 x 25 mm area and 40 x 70 mm area plus arm is heavy. .
Age: 56.0
Sex: F
Vaccine: PPV, TD, DT, PPV
Symptoms: Pyrexia, Urticaria
Clinical narrative: Redness upper arm with swelling, brachial area of injection 12 x 25 mm area and 40 x 70 mm area plus arm is heavy. .
Age: 1.25
Sex: F
Vaccine: DTAP, HIBV, MMR, PNC
Symptoms: Skin nodule
Clinical narrative: 1cm in diameter nodule on one right thigh.
Age: 60.0
Sex: U
Vaccine: PPV
Symptoms: Headache, Injection site hypersensitivity, Injection site oedema, Injection site warmth, Pain
Clinical narrative: Slight headache evening of shot 09/19/2005 headache worse next morning, body aches around noon 09/20/2005. Arm became more swollen (where shot was given), red and hot. Fever by 6pm 102 lasted for 24 hrs. Arm still sore on 09/27/2005.
Age: 60.0
Sex: U
Vaccine: PPV
Symptoms: Pyrexia
Clinical narrative: Slight headache evening of shot 09/19/2005 headache worse next morning, body aches around noon 09/20/2005. Arm became more swollen (where shot was given), red and hot. Fever by 6pm 102 lasted for 24 hrs. Arm still sore on 09/27/2005.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Cellulitis, Feeling hot, Injection site hypersensitivity, Injection site induration, Oedema
Clinical narrative: Redness, swelling right upper arm noticed evening after >24 hours after immunization given. Redness and mild induration, increased warmth 12 x 15cm diameters no fever.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Pyrexia
Clinical narrative: Redness, swelling right upper arm noticed evening after >24 hours after immunization given. Redness and mild induration, increased warmth 12 x 15cm diameters no fever.
Age: 1.63
Sex: M
Vaccine: DTAP
Symptoms: Feeling hot, Hypersensitivity, Oedema
Clinical narrative: right leg red, warm, swelling.
Age: 5.0
Sex: M
Vaccine: DTAP, HEPA, IPV
Symptoms: Erythema, Gait disturbance, Hypokinesia, Oedema
Clinical narrative: Immunizations given at noon, swelling noted at 8:30 in am right thigh to knee, unable to bend knee, Pt with limping. Erythema. swelling decreased with Ibuprofen.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV
Symptoms: Contusion, Injection site oedema, Injection site warmth
Clinical narrative: Left leg bruised, swollen and hot to touch at bottom immunization site. Contacting doctors office did not clarify which immunization caused reaction. Was informed that it probably was IPV.